72 Investment 13F annual report
72 Investment is an investment fund managing more than $67.1 billion ran by Jason Colombo. There are currently 7 companies in Mr. Colombo’s portfolio. The largest investments include Korro Bio Inc and Lenz Therapeutics Inc, together worth $47.6 billion.
$67.1 billion Assets Under Management (AUM)
As of 8th May 2024, 72 Investment’s top holding is 276,831 shares of Korro Bio Inc currently worth over $24.9 billion and making up 37.1% of the portfolio value.
In addition, the fund holds 1,017,751 shares of Lenz Therapeutics Inc worth $22.7 billion.
The third-largest holding is Alto Neuroscience Inc worth $10.3 billion and the next is Praxis Precision Medicines I worth $4.02 billion, with 65,933 shares owned.
Currently, 72 Investment's portfolio is worth at least $67.1 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at 72 Investment
The 72 Investment office and employees reside in Stamford, Connecticut. According to the last 13-F report filed with the SEC, Jason Colombo serves as the Authorized Person at 72 Investment.
Recent trades
In the most recent 13F filing, 72 Investment revealed that it had opened a new position in
Korro Bio Inc and bought 276,831 shares worth $24.9 billion.
On the other hand, there are companies that 72 Investment is getting rid of from its portfolio.
72 Investment closed its position in Prometheus Biosciences Inc on 15th May 2024.
It sold the previously owned 1,848,024 shares for $109 million.
One of the smallest hedge funds
The two most similar investment funds to 72 Investment are Dsc Advisors, L.P. and American Asset Management Inc. They manage $67.1 billion and $66.9 billion respectively.
The complete list of 72 Investment trades based on 13F SEC filings
These positions were updated on May 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Korro Bio Inc |
Opened
276,831
|
$24,914,790,000 | 37.14% |
| Lenz Therapeutics Inc |
Opened
1,017,751
|
$22,726,380,000 | 33.88% |
| Alto Neuroscience Inc |
Opened
667,778
|
$10,250,392,000 | 15.28% |
| Praxis Precision Medicines I |
Opened
65,933
|
$4,023,232,000 | 6.00% |
| Caribou Biosciences Inc |
No change
474,067
|
$2,436,704,000 | 3.63% |
| Turnstone Biologics Corp |
Opened
549,981
|
$1,440,950,000 | 2.15% |
| Omega Therapeutics Inc |
No change
352,941
|
$1,288,235,000 | 1.92% |
| Prometheus Biosciences Inc |
Closed
1,848,024
|
$109,052,000 | |
| Entrada Therapeutics Inc |
Closed
509,023
|
$8,022,000 | |
| Praxis Precision Medicines I |
Closed
988,995
|
$2,245,000 | |
| No transactions found | |||
| Showing first 500 out of 10 holdings | |||
Hedge funds similar to 72 Investment
- Longitude (cayman)
- Ll Funds
- Ergoteles
- Trustees Of Columbia University In The City Of New York
- Meditor Ltd
- River Oaks Capital
- Eaton Vance Management
- Dsc Advisors, L.P.
- American Asset Management Inc
- Dan L Duncan Foundation
- Dryden Capital
- One William Street Capital Management, L.P.
- Signify Wealth
- Collaborative Management L.P.